Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Clinical outcomes of Ultima Smart Toric (UST) customized intraocular lens (IOL) implantation for very high astigmatism following keratoplasty

Search Title by author or title

Session Details

Session Title: Pseudophakic IOLs: Toric II

Session Date/Time: Sunday 11/09/2016 | 16:00-18:00

Paper Time: 16:06

Venue: Auditorium C6

First Author: : H.Matalia INDIA

Co Author(s): :    N. C                    

Abstract Details

Purpose:

Toric IOL implantation is a safe and predictable method to provide excellent visual outcomes in cases with corneal astigmatism. Post-keratoplasty cataract cases may pose a challage with very high corneal astigmatism. We would like to report the clinical outcomes of Ultima Smart Toric (UST) customized IOL for very high astigmatism following keratoplasty cataract surgery.

Setting:

It was interventional cases series, wherein cases of cataract surgery with high astigmatism following keratoplasty, which were treated with customized UST IOL were included. All the cases were performed by the single surgeon and the IOL used were of same type.

Methods:

4 eyes of 4 patient underwent phaco with customized UST IOL implantation. The UST-IOL were customized for axis and diopter of clylinder correction so that they did not require any rotation and were implanted at 0-180 degree axis. All patients were evaluated preoperatively and postoperatively for uncorrected visual acuity (UCVA), best-spectacle corrected visual acuity (BCVA) and endothelial count.

Results:

Postoperatively, all patients had good distance unaided visual acuity. All four patients in this study had undergone keratoplasty in which three patients had keratoconus and the other one had macular corneal dystrophy. Preop astigmatism was 9 D, 9.5 D, 14 D and 20 D. Preoperative UCVA was counting finger close to face, 6/60, 6/24 and 6/60. Preoperative endothelium count was, 482, 492, 1527 and 492 cells/mm2. Postoperatively UCVA improved to 20/50, 20/40, 20/50 and 20/40. BCVA improved to 20/30, 20/30, 20/30 and 20/20. Endothelial count remain stable. None of the patient had any diplopia or visual disturbance.

Conclusions:

Management of very high astigmatism following keratoplasty is challenging. Customized UST IOL offers an effective treatment option for post-keratoplasty cataract with high corneal astigmatism.

Financial Disclosure:

NONE

Back to previous